Bhinneka News Online: Reuters Health Report: October 2, 2017

Monday, 2 October 2017

Reuters Health Report: October 2, 2017

Click to View in Browser

Monday, October 2, 2017

Health experts zero in on camels to fight deadly MERS virus

GENEVA (Reuters) - The fight against the deadly Middle East Respiratory Syndrome (MERS), which has killed at least 722 people over the past five years, is honing in on its target: camels.

Belgian biotech Ablynx scores big hit with blood disease drug

(Reuters) - Belgian biotech company Ablynx reported resoundingly positive data for an experimental drug against a rare blood disorder on Monday, sending its market value above $1.1 billion.

U.S. invests $170 million in late-stage Ebola vaccines, drugs

CHICAGO (Reuters) - The U.S. government is investing more than $170 million to help two new vaccines against the Ebola virus and two Ebola drugs complete the steps needed for approval from the Food and Drug Administration.

Exclusive: Immunotherapy developer Dynavax explores options for Hepatitis B drug-sources

(Reuters) - Dynavax Technologies Corporation, a biotechnology company focused on drugs that harness the immune system to combat disease, is reviewing strategic options for its hepatitis B vaccine, which could include a potential sale or licensing deal, people familiar with the matter said.

Company founded by Shkreli off the hook in $43 million lawsuit: judge

NEW YORK (Reuters) - Vyera Pharmaceuticals, formerly known as Turing Pharmaceuticals, does not have to pay Impax Laboratories Inc $43 million in a dispute stemming from Turing founder Martin Shkreli's decision to boost by 5,000 percent the price of a drug Turing bought from Impax, a U.S. judge ruled on Friday.

U.S. judge clears way for Maryland drug price-gouging law

(Reuters) - A U.S. District Court judge on Friday cleared the way for Maryland to implement the nation's first law designed to penalize drugmakers for price gouging by denying the generic drug industry trade group's request for an injunction.

One million unvaccinated Venezuelan kids vulnerable in measles outbreak: doctors

CARACAS (Reuters) - Around 1 million unvaccinated Venezuelan children are susceptible to measles, a highly contagious disease that has re-emerged in the crisis-stricken South American nation, a group of doctors estimated on Friday.

One episode of postpartum depression raises likelihood of more

(Reuters Health) - Depression after giving birth is rare among women with no history of psychiatric disorders, but once "postpartum depression" occurs, the odds are much higher that it will happen again after subsequent births, researchers say.

Yemen cholera cases could hit 1 million by year-end: Red Cross

GENEVA (Reuters) - The humanitarian situation in Yemen is a "catastrophe", and cholera cases could reach a million by the end of the year, the International Committee of the Red Cross said on Friday.

FDA proposes 1-1/2-year delay to nutrition label changes

(Reuters) - The U.S. Food and Drug Administration on Friday proposed giving manufacturers an extra 1-1/2 years to comply with new nutrition label requirements on packaged foods.